๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Engineering antibody affinity and specificity

โœ Scribed by D. M. Webster; S. Roberts; J. C. Cheetham; R. Griest; A. R. Rees


Publisher
John Wiley and Sons
Year
1988
Tongue
French
Weight
375 KB
Volume
41
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


A combination of ab initio calculations, "knowledge-based prediction", molecular graphics and site-directed mutagenesis has enabled us to probe the molecular details of antibody:antigen recognition and binding and to alter the affinity and specificity of an antibody for its antigen. The significance of electrostatic hydrogen bonding, hydrophilic/hydrophobic patch matching and van der Waals interactions as well as CDR:CDR interactions are discussed in relation to the results of site-directed mutagenesis experiments on the anti-lysozyme antibody Gloop2. The ability to generate reconstructed antibodies, chimeric antibodies, catalytic antibodies and the use of modelled antibodies for the design of drugs is discussed.


๐Ÿ“œ SIMILAR VOLUMES


Immunoglobulin specificity of TG19318: a
โœ Giorgio Fassina; Antonio Verdoliva; Giovanna Palombo; Menotti Ruvo; Giovanni Cas ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 198 KB ๐Ÿ‘ 1 views

A synthetic ligand [TG19318], able to mimic protein A in the recognition of the immunoglobulin Fc portion, has been previously identified in our laboratory through the synthesis and screening of multimeric combinatorial peptide libraries. In this study we have fully characterized its applicability i

Engineering T lymphocyte antigen specifi
โœ Reinder L. H. Bolhuis; Els Sturm; Jan Willem Gratama; Eric Braakman ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 489 KB

Targetingof immune cells by bispecific antibodies has proven to be a powerful tool for the investigation of cellular cytotoxicity, lymphocyte activation and induction of cytokine production, as well as to represent an innovative form of immunotherapy for the treatment of cancer. The hallmark of this